✦ LIBER ✦

Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy

✍ Scribed by J. D. Amsterdam; G. Wang; J. Shults

Book ID: 109342730
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 149 KB
Volume: 121
Category: Article
ISSN: 0001-690X
DOI: 10.1111/j.1600-0447.2009.01462.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Venlafaxine monotherapy in women with bi

Venlafaxine monotherapy in women with bipolar II and unipolar major depression

✍ Jay D Amsterdam; Felipe Garcia-España 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Venlafaxine versus lithium monotherapy o

Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: A randomized, parallel group, open-label trial

✍ Jay D. Amsterdam; Chia-Hao Wang; Michelle Shwarz; Justine Shults 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 469 KB

Episode frequency prior to lithium treat

Episode frequency prior to lithium treatment in bipolar manic-depressive patients

✍ David L. Dunner; Daniel Murphy; Frank Stallone; Ronald R. Fieve 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 467 KB

Mood response and polysomnographic effec

Mood response and polysomnographic effects of a combined venlafaxine/trimipramine therapy in depressed patients with poor response to trimipramine monotherapy

✍ U. Hemmeter; U. Brüderlin; M. Hatzinger; E. Holsboer-Trachsler 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Olanzapine monotherapy for acute depress

Olanzapine monotherapy for acute depression in patients with bipolar I or II disorder: results of an 8-week open label trial

✍ William V. Bobo; Richard A. Epstein; Richard C. Shelton 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract We evaluated the efficacy, tolerability, and safety of olanzapine monotherapy in 20 adult patients with bipolar I or II disorder, depressed phase. Patients received open‐label olanzapine monotherapy (mean modal dose, 15 mg/day) for 8 weeks. Assessments of psychopathology (Montgomery–Asb

Quetiapine monotherapy in the treatment

Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study

✍ E Vieta; JR Calabrese; JM Goikolea; S Raines; W Macfadden; for the BOLDER Study 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 655 KB